Nuveen Large Cap Value Index Fund I Class
THCVX
NASDAQ
| Weiss Ratings | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Nuveen | |||
| Manager/Tenure (Years) | Philip James(Jim) Campagna (20), Darren Tran (7), Nazar Romanyak (2) | |||
| Website | http://www.nuveen.com | |||
| Fund Information | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Nuveen Large Cap Value Index Fund I Class | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth and Income | |||
| Inception Date | Dec 04, 2015 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 100,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.53% | |||
| Dividend | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.74% | |||
| Asset Allocation | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.06% | |||
| Stock | 99.93% | |||
| U.S. Stock | 99.01% | |||
| Non-U.S. Stock | 0.92% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.00% | |||
| 30-Day Total Return | -2.61% | |||
| 60-Day Total Return | -1.52% | |||
| 90-Day Total Return | 1.35% | |||
| Year to Date Total Return | 19.89% | |||
| 1-Year Total Return | 23.61% | |||
| 2-Year Total Return | 37.15% | |||
| 3-Year Total Return | 77.25% | |||
| 5-Year Total Return | 73.18% | |||
| Price | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $33.57 | |||
| 1-Month Low NAV | $33.36 | |||
| 1-Month High NAV | $34.78 | |||
| 52-Week Low NAV | $27.78 | |||
| 52-Week Low NAV (Date) | Dec 17, 2025 | |||
| 52-Week High NAV | $34.78 | |||
| 52-Week High Price (Date) | Sep 03, 2026 | |||
| Beta / Standard Deviation | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.79 | |||
| Standard Deviation | 12.33 | |||
| Balance Sheet | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 12.90B | |||
| Operating Ratios | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.14% | |||
| Turnover Ratio | 31.00% | |||
| Performance | THCVX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 25.41% | |||
| Last Bear Market Total Return | -12.23% | |||